{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:34:18Z","timestamp":1793090058536,"version":"4.5.0"},"reference-count":29,"publisher":"American Society for Microbiology","issue":"14","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2005,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>The need to replace rabies immune globulin (RIG) as an essential component of rabies postexposure prophylaxis is widely acknowledged. We set out to discover a unique combination of human monoclonal antibodies (MAbs) able to replace RIG. Stringent criteria concerning neutralizing potency, affinity, breadth of neutralization, and coverage of natural rabies virus (RV) isolates and in vitro escape mutants were set for each individual antibody, and the complementarities of the two MAbs were defined at the onset. First, we identified and characterized one human MAb (CR57) with high in vitro and in vivo neutralizing potency and a broad neutralization spectrum. The linear antibody binding site was mapped on the RV glycoprotein as antigenic site I by characterizing CR57 escape mutants. Secondly, we selected using phage display a complementing antibody (CR4098) that recognized a distinct, nonoverlapping epitope (antigenic site III), showed similar neutralizing potency and breadth as CR57, and neutralized CR57 escape mutants. Reciprocally, CR57 neutralized RV variants escaping CR4098. Analysis of glycoprotein sequences of natural RV isolates revealed that the majority of strains contain both intact epitopes, and the few remaining strains contain at least one of the two. In vitro exposure of RV to the combination of CR57 and CR4098 yielded no escape mutants. In conclusion, a novel combination of human MAbs was discovered suitable to replace RIG.<\/jats:p>","DOI":"10.1128\/jvi.79.14.9062-9068.2005","type":"journal-article","created":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T02:29:34Z","timestamp":1120184974000},"page":"9062-9068","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":138,"title":["Novel Human Monoclonal Antibody Combination Effectively Neutralizing Natural Rabies Virus Variants and Individual In Vitro Escape Mutants"],"prefix":"10.1128","volume":"79","author":[{"given":"Alexander B. H.","family":"Bakker","sequence":"first","affiliation":[{"name":"Crucell Holland BV, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfred E.","family":"Marissen","sequence":"additional","affiliation":[{"name":"Crucell Holland BV, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Arjen","family":"Kramer","sequence":"additional","affiliation":[{"name":"Crucell Holland BV, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy B.","family":"Rice","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Weldon","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Division of Viral and Rickettsial Diseases, Rabies Section, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Niezgoda","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Division of Viral and Rickettsial Diseases, Rabies Section, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen A.","family":"Hanlon","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Division of Viral and Rickettsial Diseases, Rabies Section, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Thijsse","sequence":"additional","affiliation":[{"name":"Crucell Holland BV, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold H. J.","family":"Backus","sequence":"additional","affiliation":[{"name":"Crucell Holland BV, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"de Kruif","sequence":"additional","affiliation":[{"name":"Crucell Holland BV, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Dietzschold","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Rupprecht","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Division of Viral and Rickettsial Diseases, Rabies Section, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"Goudsmit","sequence":"additional","affiliation":[{"name":"Crucell Holland BV, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.8.4198-4203.1991"},{"key":"e_1_3_2_3_2","first-page":"228","volume":"48","year":"1999","unstructured":"Centers for Disease Control and Prevention. 1999. Mass treatment of humans who drank unpasteurized milk from rabid cows-Massachusetts, 1996-1998. Morb. Mortal. Wkly. Rep.48:228-229.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_4_2","first-page":"761","volume":"48","year":"1999","unstructured":"Centers for Disease Control and Prevention. 1999. Multiple human exposures to a rabid bear cub at a petting zoo and barnwarming-Iowa, August 1999. Morb. Mortal. Wkly. Rep.48:761.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.1.273-278.1998"},{"key":"e_1_3_2_6_2","first-page":"3","volume":"17","year":"1986","unstructured":"Diallo, A. 1986. Avirulent mutants of the rabies virus: change in site III of the glycoprotein. Ann. Rech. Vet.17:3-6. (In French.)","journal-title":"Ann. Rech. Vet."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.6.3087-3090.1990"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(87)90167-X"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.1.70"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1089\/hyb.1991.10.547"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1998.9.13-1909"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1993.1261"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00135-9"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00516-8"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2002.63.1096"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-83-12-3045"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2003.tb03412.x"},{"key":"e_1_3_2_18_2","first-page":"219","volume":"57","year":"1984","unstructured":"Lafon, M., J. Ideler, and W. H. Wunner. 1984. Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies. Dev. Biol. Stand.57:219-225.","journal-title":"Dev. Biol. Stand."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-64-4-843"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.8.4672-4678.2005"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(93)90052-Y"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.62.1.1-7.1988"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/375247"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.7589\/0090-3558-25.4.548"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114260"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.53.3.926-934.1985"},{"key":"e_1_3_2_27_2","first-page":"28","year":"1996","unstructured":"Tordo, N. 1996. Characteristics and molecular biology of rabies virus, p. 28-51. In F.-X. Meslin, M. M Kaplan, and H. Koprowski (ed.), Laboratory techniques in rabies, 4th ed. World Health Organization, Geneva, Switzerland.","journal-title":"Laboratory techniques in rabies"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.24.7250"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(89)90122-0"},{"key":"e_1_3_2_30_2","unstructured":"World Health Organization. 2002. Monoclonal antibody cocktail for rabies post exposure treatment: report of a WHO consultation 23-24 May 2002. World Health Organization document R2-370-15. World Health Organization Geneva Switzerland."}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.79.14.9062-9068.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.79.14.9062-9068.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T04:23:12Z","timestamp":1646454192000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.79.14.9062-9068.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":29,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["10.1128\/JVI.79.14.9062-9068.2005"],"URL":"https:\/\/doi.org\/10.1128\/jvi.79.14.9062-9068.2005","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.8233.465723","asserted-by":"object"}]},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"2005-02-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-04-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}